PCI Biotech: Third quarter 2012 report

October 30, 2012 03:00 ET | Source: PCI Biotech Holding ASA PCI Biotech Holding ASA

Oslo, Norway, 30 October 2012.

Please find attached the third quarter 2012 report for PCI Biotech Holding ASA.

Kind regards,

Per Walday
CEO

Email: pw@pcibiotech.no
Mobil: +47 917 93 429

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachments

PCI Biotech Q3 2012 Report...

Recommended Reading

January 29, 2026 11:50 ET | Source: PCI Biotech Holding ASA

PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process

Oslo (Norway), 29 January 2026 – PCI Biotech (OSE: PCIB) refers to its latest announcement of 8 January 2026 regarding the discontinuation of all R&D operations and the continued exploration of...
Read More
January 08, 2026 08:10 ET | Source: PCI Biotech Holding ASA

PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options

Oslo (Norway), 8 January 2026 – PCI Biotech (OSE: PCIB). Reference is made to the company’s latest announcement dated 23rd October 2025. The external evaluation of a new bioprocessing technology has...
Read More